The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders
Open accessAbstract
OBJECTIVE: The objective of this study was to provide national estimates of psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders and to examine child and health system characteristics associated with psychotropic medication use. METHODS: This cross-sectional study used Medicaid claims for calendar year 2001 from all 50 states and Washington, DC, to examine 60,641 children with an autism spectrum disorder diagnosis. Logistic regression with random effects was used to examine the child, county, and state factors associated with psychotropic medication use. RESULTS: Of the sample, 56% used at least 1 psychotropic medication, 20% of whom were prescribed > or = 3 medications concurrently. Use was common even in children aged 0 to 2 years (18%) and 3 to 5 years (32%). Neuroleptic drugs were the most common psychotropic class (31%), followed by antidepressants (25%) and stimulants (22%). In adjusted analyses, male, older, and white children; those who were in foster care or in the Medicaid disability category; those who received additional psychiatric diagnoses; and those who used more autism spectrum disorder services were more likely to have used psychotropic drugs. Children who had a diagnosis of autistic disorder or who lived in counties with a lower percentage of white residents or greater urban density were less likely to use such medications. CONCLUSIONS: Psychotropic medication use is common among even very young children with autism spectrum disorders. Factors unrelated to clinical presentation seem highly associated with prescribing practices. Given the limited evidence base, there is an urgent need to assess the risks, benefits, and costs of medication use and understand the local and national policies that affect medication use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mandell et al. reported that 56% were prescribed at least one psychotropic medication and 20% were prescribed three or more [27].”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
The American Society of Health System Pharmacists
Beard, E. L. (2001) · JONA s Healthcare Law Ethics and Regulation · doi:10.1097/00128488-200109000-00003 · Cited by 1,685
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248
Factors Associated With Age of Diagnosis Among Children With Autism Spectrum Disorders
Mandell, D. S., Novak, M. M., & Zubritsky, C. D. (2005) · Pediatrics · doi:10.1542/peds.2005-0185 · Cited by 896
Self-citationInternational Classification of Diseases, Ninth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/bd1nux · Cited by 891
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Research works printed but not linked: 1
- Bonferroni C. The calculation for the protection against groups of tests. In: Studies in Honor of Professor Salvatore Ortu Carboni. [in Italian] Rome, Italy;1935:13–60
Cited by
Sorted by citations
Items 101–200 of 295
A transdiagnostic model of psychiatric symptom co‐occurrence and autism spectrum disorder
Rodriguez-Seijas, C. A., Gadow, K. D., Rosen, T. E., hyunsik, K., Lerner, M. D., & Eaton, N. R. (2019) · Autism Research · doi:10.1002/aur.2228 · Cited by 27
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid
Rast, J. E., Tao, S., Schott, W., Shea, L., Brodkin, E. S., Kerns, C. M., Leonard, C. E., Murray, M. J., & Lee, B. K. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06182-5 · Cited by 29
Eleven Years of Clozapine Experience in Autism Spectrum Disorder
Rothärmel, M., Szymoniak, F., Pollet, C., Beherec, L., Quesada, P., Leclerc, S., Belhaïne, A., Rosier, A., & Guillin, O. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000955 · Cited by 30
Psychotropic medications for highly vulnerable children
McLaren, J., Barnett, E. R., Concepción-Zayas, M. T., Lichtenstein, J. D., Acquilano, S. C., Schwartz, L. M., Woloshin, S., & Drake, R. E. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1445720 · Cited by 29
Bishop, J. R., Najjar, F., Rubin, L. H., Guter, S. J., Owley, T. B., Mosconi, M. W., Jacob, S., & Cook, E. H. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000173 · Cited by 28
Geng, Y., Yates, C. M., & Peterson, R. T. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100381 · Cited by 27
Soria-Saucedo, R., Liu, X., Hincapie‐Castillo, J. M., Zambrano, D. H., Bussing, R., & Winterstein, A. G. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201700260 · Cited by 27
Psychopharmacology of autism spectrum disorders: A selective review
Mohiuddin, S. S., & Ghaziuddin, M. (2012) · Autism · doi:10.1177/1362361312453776 · Cited by 27
Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study
Firouzabadi, N., Ghazanfari, N., Shoushtari, A. A., Erfani, N., Fathi, F., Bazrafkan, M., & Bahramali, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153667 · Cited by 26
Use of allied‐health services and medication among adults with ASD in Latin America
Torres, A., Lecusay, D., Valdez, D., Rosoli, A., Garrido, G., Cukier, S., Paula, C. S., García, R. N., Rattazzi, A., & Montiel‐Nava, C. (2021) · Autism Research · doi:10.1002/aur.2583 · Cited by 25
Mandell, D. S., Morales, K. H., Xie, M., Polsky, D. E., Stahmer, A. C., & Marcus, S. C. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-0982-2 · Cited by 25
Self-citationBenevides, T. W., Carretta, H. J., Rust, G. S., & Shea, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251353 · Cited by 24
Williams, M. E., & Haranin, E. C. (2016) · Journal of Mental Health Research in Intellectual Disabilities · doi:10.1080/19315864.2016.1166302 · Cited by 24
Tesfaye, R., Wright, N., Zaidman‐Zait, A., Bedford, R., Zwaigenbaum, L., Kerns, C. M., Duku, E., Mirenda, P., Bennett, T. A., Georgiades, S., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab122 · Cited by 24
Psychotropic Medication Use in Children With Autism in the Kentucky Medicaid Population
Williams, P. G., Woods, C. R., Stevenson, M. D., Davis, D. W., Radmacher, P. G., & Smith, M. J. (2012) · Clinical Pediatrics · doi:10.1177/0009922812440837 · Cited by 22
Pharmacogenomics of Autism Spectrum Disorder
Brown, J. T., Eum, S., Cook, E. H., & Bishop, J. R. (2017) · Pharmacogenomics · doi:10.2217/pgs-2016-0167 · Cited by 24
Logan, S. L., Carpenter, L. A., Leslie, R. S., Hunt, K. S., Garrett-Mayer, E. S., Charles, J. M., & Nicholas, J. S. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2156-0 · Cited by 24
Autism severity as a predictor of inattention and impulsivity in toddlers
Tureck, K., Matson, J. L., Cervantes, P. E., & Turygin, N. C. (2013) · Developmental Neurorehabilitation · doi:10.3109/17518423.2013.807884 · Cited by 24
Grosse, S. D., Nichols, P., Nyarko, K. A., Maenner, M. J., Danielson, M. L., & Shea, L. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05269-1 · Cited by 22
Lake, J., Denton, D., Lunsky, Y., Shui, A., Veenstra-VanderWeele, J., & Anagnostou, E. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3058-8 · Cited by 23
Hollway, J. A., Mendoza-Burcham, M., Andridge, R., Aman, M. G., Handen, B. L., Arnold, L. E., Lecavalier, L., Williams, C. E., Silverman, L. B., & Smith, T. H. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0085 · Cited by 23
Therapy and Psychotropic Medication Use in Young Children With Autism Spectrum Disorder
Ziskind, D., Bennett, A. E., Jawad, A. F., & Blum, N. J. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1895m · Cited by 22
Lake, J. K., Weiss, J. A., Dergal, J. M., & Lunsky, Y. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0011 · Cited by 21
House, S. A., Goodman, D. C., Weinstein, S. J., Chang, C., Wasserman, J. R., & Morden, N. E. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.027 · Cited by 21
Psychotropic Use Among Youths With Intellectual and Developmental Disabilities
McLaren, J., Lichtenstein, J. D., Metcalfe, J. D., Charlot, L., Drake, R. E., & Beasley, J. B. (2021) · Psychiatric Services · doi:10.1176/appi.ps.201900465 · Cited by 21
Patterns of Care for Rural and Urban Children with Mental Health Problems
Ms, A., Neuwirth, S. J., Mhs, J. D. L., & Hartley, M. (2013) · Cited by 20
Lunsky, Y., Lake, J. K., Durbin, J., Perry, A., Bullock, H. L., Morris, S., & Lee, J. S. (2014) · International review of research in developmental disabilities · doi:10.1016/b978-0-12-800278-0.00001-4 · Cited by 20
Khanna, R., Jariwala, K., & West-Strum, D. S. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2012.01563.x · Cited by 20
Murphy, D., Glaser, K., Hayward, H., Eklund, H., Cadman, T., Findon, J., Woodhouse, E., Ashwood, K., Beecham, J., Bolton, P., et al. (2018) · Programme Grants for Applied Research · doi:10.3310/pgfar06020 · Cited by 18
“For instance, one study reported that rates of psychotropic drug use rose from 56% for 6- to 11-year-olds to 73% for 18- to 21-year-olds.(288) This is of importance because once an individual has been prescribed a psychotropic medication, they are (1) 11 times more likely to remain on it than they would a non-psychotr…”
BackgroundQuebles, I., Solomon, O., Smith, K. A., Rao, S. R., Lu, F., Azen, C. G., Anaya, G., & Yin, L. (2020) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-125.5.369 · Cited by 20
Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders
Duvall, S. W., Lindly, O. J., Zuckerman, K. E., Msall, M. E., & Weddle, M. (2019) · PEDIATRICS · doi:10.1542/peds.2018-0558 · Cited by 18
Weeden, M., Ehrhardt, K. E., & Poling, A. D. (2010) · Behavior Analysis in Practice · doi:10.1007/bf03391753 · Cited by 18
Mirror neuron system based therapy for emotional disorders
Yuan, T., & Hoff, R. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.004 · Cited by 18
Jessel, J., Rosenthal, D., Hanley, G. P., Rymill, L., Boucher, M. B., Howard, M. R., Perrin, J., & Lemos, F. M. (2021) · Behavior Modification · doi:10.1177/01454455211010698 · Cited by 17
Autism familiarity and knowledge among pharmacy students
Khanna, R., Jariwala, K., Holmes, E. R., & Ramachandran, S. (2013) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2013.09.010 · Cited by 17
Psychotropic Medications as Treatments for People with Autism Spectrum Disorder
Poling, A. D., Ehrhardt, K. E., & Li, A. (2017) · Autism and child psychopathology series · doi:10.1007/978-3-319-61738-1_25 · Cited by 17
Foster Children With Autism Spectrum Disorder: Prevalence, Length of Stay, and Placement Patterns
Bilaver, L., & Havlicek, J. R. (2013) · Journal of Public Child Welfare · doi:10.1080/15548732.2013.843496 · Cited by 17
Lake, J. K., Vogan, V. M., Sawyer, A., Weiss, J. A., & Lunsky, Y. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0106 · Cited by 15
Bowden, N., Thabrew, H., Kokaua, J., & Braund, R. (2020) · Research in Autism · doi:10.1016/j.rasd.2020.101642 · Cited by 16
Shawahna, R. (2021) · BMC Nursing · doi:10.1186/s12912-021-00764-3 · Cited by 15
Kamimura-Nishimura, K. I., Froehlich, T. E., Chirdkiatgumchai, V., Adams, R. E., Fredstrom, B. K., & Manning-Courtney, P. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.06.001 · Cited by 16
Beyond biomedicine: challenging conventional conceptualisations of autism spectrum conditions
Cárthaigh, S. M. (2019) · Disability & Society · doi:10.1080/09687599.2019.1605884 · Cited by 21
Oswald, D. P., & Haworth, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-25501-9_17 · Cited by 16
Shurtz, L., Schwartz, C., DiStefano, C., McPartland, J. C., Levin, A. R., Dawson, G., Kleinhans, N. M., Faja, S., Webb, S. J., Shic, F., et al. (2022) · Autism · doi:10.1177/13623613221121425 · Cited by 13
YILMAZ, Z. K., & Al‐Taie, A. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01530-4 · Cited by 13
Hong, M., Lee, S. Y., Han, J., Park, J. C., Lee, Y. J., Hwangbo, R., Chang, H., Cho, S. W., Bhang, S., Kim, B., et al. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.10.1687 · Cited by 13
Lewis, A. S., & van Schalkwyk, G. I. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-03942-0 · Cited by 14
Mental Health Trends in Military Pediatrics
Hisle-Gorman, E. J., Susi, A., & Gorman, G. H. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800101 · Cited by 13
Wiggins, L. D., Nadler, C. B., Rosenberg, S. A., Moody, E. J., Reyes, N., Reynolds, A., Alexander, A. A., Daniels, J. L., Thomas, K. C., Giarelli, E., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.01.043 · Cited by 13
Freitag, C. M., & Jarczok, T. A. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_13 · Cited by 13
Hess, J. A., Matson, J. L., Neal, D., Mahan, S., Fodstad, J. C., Bamburg, J. W., & Holloway, J. (2010) · Journal of Mental Health Research in Intellectual Disabilities · doi:10.1080/19315861003690588 · Cited by 13
Yoshida, K., Lunsky, Y., Müller, D. J., & Desarkar, P. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06208-y · Cited by 12
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Aishworiya, R., Valica, T., Hagerman, R. J., & Restrepo, B. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.24022006 · Cited by 16
Pesko, M. J., Burbige, E. M., Sannar, E. M., Beresford, C. A., Rogers, C., Ariefdjohan, M. W., & Stutzman, D. L. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.2.149 · Cited by 12
Myers, S. M., & Challman, T. D. (2018) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610021357-19 · Cited by 12
Medical Care Burden of Children with Autism Spectrum Disorders
Lin, J. (2014) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-014-0023-8 · Cited by 13
Symptom scores and medication treatment patterns in children with ADHD versus autism
Mayes, S. D., Waxmonsky, J. G., Baweja, R. K., Mattison, R. E., Memon, H., Klein, M., Hameed, U., & Waschbusch, D. A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112937 · Cited by 12
Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder
Rast, J. E., Anderson, K. A., Roux, A. M., & Shattuck, P. T. (2021) · Academic Pediatrics · doi:10.1016/j.acap.2020.05.015 · Cited by 12
Ethical Prescribing of Psychotropic Medications for People with Neurodevelopmental Disorders
Deb, S. S., Limbu, B., Bianco, A., & Bertelli, M. O. (2023) · Advances in Neurodevelopmental Disorders · doi:10.1007/s41252-023-00365-y · Cited by 11
Louw, K.-A., Bentley, J., Sorsdahl, K. R., & Adnams, C. M. (2013) · Journal of Child and Adolescent Mental Health · doi:10.2989/17280583.2013.767265 · Cited by 11
Sclabassi, E., Peret, S., Qian, C., & Gao, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13123025 · Cited by 11
Obesity Prevention and Screening
Mackey, E. R., Olson, A. M., Difazio, M. P., & Cassidy, O. L. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2015.08.009 · Cited by 10
Jackel, C. R., Justine Shults, A., Wiley, S., Meinzen‐Derr, J. K., Augustyn, M. C., & Blum, N. J. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000488 · Cited by 10
Barnard-Brak, L. M., Davis, T. N., Schmidt, M., & Richman, D. M. (2014) · Developmental Neurorehabilitation · doi:10.3109/17518423.2014.904949 · Cited by 12
Is fever a predictive factor in the autism spectrum disorders?
Megremi, A. S. F. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.01.007 · Cited by 10
McQuaid, G. A., Duane, S. C., Ahmed, N., Lee, N., Charlton, R. A., & Wallace, G. L. (2023) · Autism Research · doi:10.1002/aur.3076 · Cited by 12
High-Dose Propranolol for Severe and Chronic Aggression in Autism Spectrum Disorder
London, E., Zimmerman-Bier, B., Yoo, J. H., & Gaffney, J. W. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001895 · Cited by 9
Deb, S. S. (2024) · Autism and child psychopathology series · doi:10.1007/978-3-031-66902-6_18 · Cited by 10
Beherec, L., Quilici, G., Rosier, A., Gérardin, P., Campion, D., & Guillin, O. (2013) · L Encéphale · doi:10.1016/j.encep.2012.01.014 · Cited by 9
O’Brien, M. J., Pelzel, K. E., Hendrix, N. M., Schieltz, K. M., Miller, K., Call, N. A., Tsami, L., Lerman, D. C., Berg, W. K., Kopelman, T. G., et al. (2021) · Behavior Modification · doi:10.1177/01454455211018815 · Cited by 12
TRANSTORNO DO ESPECTRO AUTISTA
Flumignan, V. S. M., R.M., R., DEMIER, B., A.J.J., S., FALCAO, G., & SOFFIENTINI, M. (2023) · EDITORA CRV eBooks · doi:10.24824/978652513581.6.723-730 · Cited by 9
Oza, V. S., Marco, E. J., & Frieden, I. J. (2015) · Pediatric Dermatology · doi:10.1111/pde.12548 · Cited by 9
Doenyas, C., Ekici, B., Unay, Ö. S., Gönen, İ., & Tatlı, B. (2021) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2021.1937001 · Cited by 12
Psychotropic Medication Use by Children with Autism Served in Publicly Funded Mental Health Settings
Caplan, B., Chlebowski, C., May, G. C., Baker-Ericzén, M. J., Connor, W., & Brookman-Frazee, L. I. (2021) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001044 · Cited by 9
Anxiety in Children with Autism Spectrum Disorder
Jennett, H. K., Vasa, R. A., & Hagopian, L. P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_16 · Cited by 9
Psychopharmacology in Children with PDD: Review of Current Evidence
Scahill, L. D., & Boorin, S. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6975-0_8 · Cited by 9
Davis, S., Annis, I. E., Hughes, P. M., deJong, N. A., Christian, R. B., Ruble, L. A., & Thomas, K. C. (2023) · Autism in Adulthood · doi:10.1089/aut.2022.0088 · Cited by 8
Gerber, A. S., Kang, E., Nahmias, A. S., Libsack, E. J., Simson, C., & Lerner, M. D. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05559-2 · Cited by 8
Pharmacology of Autism Spectrum Disorder
Greydanus, D. E., Kaplan, G., & Patel, D. R. (2015) · Contemporary clinical neuroscience · doi:10.1007/978-1-4939-2190-4_9 · Cited by 8
Lake, J. K., Milovanov, A., Sawyer, A., & Lunsky, Y. (2014) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/1088357614559215 · Cited by 8
Sloman, K. N., Fiske, K., & LaRue, R. H. (2018) · Springer eBooks · doi:10.1007/978-3-030-00791-1_14 · Cited by 8
Weight outcomes in children with developmental disabilities from a multidisciplinary clinic
Foster, B. A., Reynolds, K., Callejo-Black, A., Polensek, N., & Weill, B. C. (2020) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2020.103809 · Cited by 10
Koegel, L. K., Krasno, A. M., TARAS, H. L., Koegel, R. L., & Frea, W. D. (2013) · School Mental Health · doi:10.1007/s12310-012-9098-5 · Cited by 8
Self, T. L., Hale, L. S., & Crumrine, D. (2010) · Language Speech and Hearing Services in Schools · doi:10.1044/0161-1461(2009/08-0106 · Cited by 7
Multiple Psychiatric Diagnoses Common in Privately Insured Children on Atypical Antipsychotics
Halloran, D. R., Swindle, J. P., Takemoto, S. K., & Schnitzler, M. A. (2010) · Clinical Pediatrics · doi:10.1177/0009922809347369 · Cited by 7
Meng, L.-C., Leonard, C. E., Candon, M. K., Mandell, D. S., & Hennessy, S. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.12.006 · Cited by 6
Self-citationCravero, C., Guinchat, V., Claret, A., Sahnoun, C., Bonniau, B., Bodeau, N., Danion-Grilliat, A., Cohen, D., & Chamak, B. (2017) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2016.10.002 · Cited by 6
Anti-Anxiety Medications and Novel Treatments for Autism
Deb, S. S., Roy, M., Limbu, B., & Bertelli, M. O. (2022) · Autism and child psychopathology series · doi:10.1007/978-3-030-88538-0_51 · Cited by 5
Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities
Farmer, C., & Aman, M. G. (2013) · International review of research in developmental disabilities · doi:10.1016/b978-0-12-401662-0.00009-9 · Cited by 5
Horovitz, M., Matson, J. L., & Barker, A. (2012) · Research in Autism · doi:10.1016/j.rasd.2011.05.013 · Cited by 5
van Haaren, F. (2016) · Behavior Analysis Research and Practice · doi:10.1037/bar0000049 · Cited by 5
Heady, N., Watkins, A. J., John, A. M., & Hutchings, H. A. (2022) · Adoption & Fostering · doi:10.1177/03085759221100585 · Cited by 5
Potential Effect of Pharmacotherapy on Sympathetic Arousal in Autism
Bujnakova, I., Ondrejka, I., Mestanik, M., Flešková, D., Sekaninova, N., Farský, I., & Tonhajzerová, I. (2017) · Acta Medica Martiniana · doi:10.1515/acm-2017-0013 · Cited by 6
Current state and future prospects of pharmacological interventions for autism
Vahabzadeh, A. B. N., Buxton, D., McDougle, C. J., & Stigler, K. A. (2013) · Neuropsychiatry · doi:10.2217/npy.13.22 · Cited by 5
Are We Overmedicating Our Children?
Harrington, J. W. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0879 · Cited by 5
Drouillard, B. (2019) · Scholarship at UWindsor (University of Windsor) · Cited by 5
Lloyd, B. P., Weaver, E. S., Torelli, J. N., Pollack, M. S., Fareed, S. A., & Maxwell-Horn, A. C. (2021) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-126.5.377 · Cited by 4
Summative content analysis of the recommendations from Project ECHO Ontario Autism
Jane, A., Kanigsberg, L., Patel, A., Eldon, S., Anagnostou, E. A., Brian, J. A., & Penner, M. (2023) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2023.1096314 · Cited by 4
Bulonza, R., Watkins, K., Parsons, R. W., Sunderland, B., Whitehouse, A., & Caccetta, R. (2024) · Autism · doi:10.1177/13623613231226099 · Cited by 4
Turgeon, M. C. D. M., Tremblay, É., Déry, N., & Guay, H. (2013) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2013.11.005 · Cited by 4
Metadata
- Authors
- Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E.
- Affiliations
- Leonard Davis Institute of Health Economics (US)
- University of Pennsylvania (US)
- Rady Children's Hospital-San Diego (US)
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-03-01
- Volume
- 121
- Issue
- 3
- Pages
- e441-e448
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC2861431
- OpenAlex
- W1980023413
- Cited by
- 295
- References
- 49
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 17 · 2023: 14 · 2022: 20 · 2021: 21 · 2020: 16 · 2019: 16 · 2018: 19 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 16 · 2013: 35 · 2012: 18
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pennsylvania
- National Institute of Mental Health (R01MH077000)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- psychotropic drug use, autism spectrum disorder, Medicaid, children, antipsychotic drugs, antidepressants, stimulants, prescribing patterns, foster care, county-level factors, racial and ethnic disparities, urban density
- MeSH terms
- Adolescent, Age Factors, Attitude of Health Personnel, Autistic Disorder, Mental Disorders, Child, Child, Preschool, Cross-Sectional Studies, Drug Utilization, Eligibility Determination, Female, Follow-Up Studies, Humans, Male, Medicaid, Practice Patterns, Physicians', Probability, Psychotropic Drugs, Retrospective Studies, Sex Factors, Multicenter Studies as Topic, Incidence, Multivariate Analysis, Treatment Outcome, Risk Assessment, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review